Geron
GERN
#5738
Rank
A$1.69 B
Marketcap
A$2.65
Share price
-2.08%
Change (1 day)
-29.29%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -A$72.15 Million

According to Geron's latest financial reports the company's current earnings are A$0.18 Billion. In 2024 the company made an earning of -A$0.23 Billion, an increase over its 2023 earnings that were of -A$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$72.15 Million-67.24%
2024 -A$0.23 Billion-11.23%
2023 -A$0.25 Billion30.22%
2022 -A$0.2 Billion20.15%
2021 -A$0.16 Billion50.08%
2020 -A$0.11 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$43.86 Million8.84%
2017 -A$40.29 Million-3.08%
2016 -A$41.57 Million-22080.6%
2015 A$0.18 M-100.38%
2014 -A$50.23 Million-7.14%
2013 -A$54.09 Million
2011 -A$0.13 Billion19.04%
2010 -A$0.11 Billion8.45%
2009 -A$99.12 Million-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$88.68 Million32.68%
2006 -A$66.84 Million25.59%
2005 -A$53.22 Million4.36%
2004 -A$51 Million19.73%
2003 -A$42.6 Million-15.46%
2002 -A$50.38 Million1.94%
2001 -A$49.42 Million33.59%
2000 -A$37 Million27.53%
1999 -A$29.01 Million63.13%
1998 -A$17.79 Million15.6%
1997 -A$15.39 Million-10.66%
1996 -A$17.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$13.95 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.24 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$97.72 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B-368.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.4 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA